Quadrant Capital Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,883
| Closed | -$700K | – | 2017 |
|
|
2025
Q1 | $700K | Buy |
3,883
+3,726
| +2,373% | +$672K | 0.03% | 539 |
|
|
2024
Q4 | $24.6K | Sell |
157
-260
| -62% | -$40.7K | ﹤0.01% | 1790 |
|
|
2024
Q3 | $75.9K | Buy |
417
+343
| +464% | +$62.4K | 0.01% | 1233 |
|
|
2024
Q2 | $13.6K | Buy |
74
+39
| +111% | +$7.16K | ﹤0.01% | 2010 |
|
|
2024
Q1 | $6.23K | Sell |
35
-10
| -22% | -$1.78K | ﹤0.01% | 2254 |
|
|
2023
Q4 | $5.58K | Buy |
45
+10
| +29% | +$1.24K | ﹤0.01% | 2247 |
|
|
2023
Q3 | $4.06K | Hold |
35
| – | – | ﹤0.01% | 2225 |
|
|
2023
Q2 | $4.11K | Hold |
35
| – | – | ﹤0.01% | 2251 |
|
|
2023
Q1 | $2.8K | Buy |
+35
| New | +$2.8K | ﹤0.01% | 2365 |
|
|
2022
Q3 | – | Sell |
-4
| Closed | – | – | 2725 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 2638 |
|
|
2022
Q1 | $0 | Sell |
4
-17
| -81% | – | ﹤0.01% | 2597 |
|
|
2021
Q4 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 2326 |
|